These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27666772)

  • 1. Dysferlin mutations and mitochondrial dysfunction.
    Vincent AE; Rosa HS; Alston CL; Grady JP; Rygiel KA; Rocha MC; Barresi R; Taylor RW; Turnbull DM
    Neuromuscul Disord; 2016 Nov; 26(11):782-788. PubMed ID: 27666772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle Cells Fix Breaches by Orchestrating a Membrane Repair Ballet.
    Barthélémy F; Defour A; Lévy N; Krahn M; Bartoli M
    J Neuromuscul Dis; 2018; 5(1):21-28. PubMed ID: 29480214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
    Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
    J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
    Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy.
    Khodabukus A; Prabhu NK; Roberts T; Buldo M; Detwiler A; Fralish ZD; Kondash ME; Truskey GA; Koves TR; Bursac N
    Adv Sci (Weinh); 2024 Aug; 11(31):e2400188. PubMed ID: 38887849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
    Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
    FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse engineering gene network identifies new dysferlin-interacting proteins.
    Cacciottolo M; Belcastro V; Laval S; Bushby K; di Bernardo D; Nigro V
    J Biol Chem; 2011 Feb; 286(7):5404-13. PubMed ID: 21119217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.
    Cacciottolo M; Numitone G; Aurino S; Caserta IR; Fanin M; Politano L; Minetti C; Ricci E; Piluso G; Angelini C; Nigro V
    Eur J Hum Genet; 2011 Sep; 19(9):974-80. PubMed ID: 21522182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.
    Gallardo E; de Luna N; Diaz-Manera J; Rojas-García R; Gonzalez-Quereda L; Flix B; de Morrée A; van der Maarel S; Illa I
    PLoS One; 2011; 6(12):e29061. PubMed ID: 22194990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysferlinopathies: Clinical and genetic variability.
    Ivanova A; Smirnikhina S; Lavrov A
    Clin Genet; 2022 Dec; 102(6):465-473. PubMed ID: 36029111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.
    Cárdenas AM; González-Jamett AM; Cea LA; Bevilacqua JA; Caviedes P
    Exp Neurol; 2016 Sep; 283(Pt A):246-54. PubMed ID: 27349407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.
    Poudel BH; Fletcher S; Wilton SD; Aung-Htut M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
    Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
    Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in myofibrillar myopathy.
    Vincent AE; Grady JP; Rocha MC; Alston CL; Rygiel KA; Barresi R; Taylor RW; Turnbull DM
    Neuromuscul Disord; 2016 Oct; 26(10):691-701. PubMed ID: 27618136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E knockout, but not cholesteryl ester transfer protein (CETP)-associated high-density lipoprotein cholesterol (HDL-C) lowering, exacerbates muscle wasting in dysferlin-null mice.
    Sun Z; White Z; Theret M; Bernatchez P
    Lipids Health Dis; 2024 Aug; 23(1):247. PubMed ID: 39138561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
    Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
    Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation.
    Fernández G; Arias-Bravo G; Bevilacqua JA; Castillo-Ruiz M; Caviedes P; Sáez JC; Cea LA
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165800. PubMed ID: 32305450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.